Fujii N, Meade RD, Minson CT, Brunt VE, Boulay P, Sigal RJ, Kenny GP. Cutaneous blood flow during intradermal NO administration in young and older adults: roles for calcium-activated potassium channels and cyclooxygenase?. Am J Physiol Regul Integr Comp Physiol 310: R1081-R1087, 2016. First published April 13 2016; doi:10.1152/ajpregu.00041.2016.-Nitric oxide (NO) increases cutaneous blood flow; however, the underpinning mechanism(s) remains to be elucidated. We hypothesized that the cutaneous blood flow response during intradermal administration of sodium nitroprusside (SNP, a NO donor) is regulated by calcium-activated potassium (KCa) channels and cyclooxygenase (COX) in young adults. We also hypothesized that these contributions are diminished in older adults given that aging can downregulate KCa channels and reduce COXderived vasodilator prostanoids. In 10 young (23 Ϯ 5 yr) and 10 older (54 Ϯ 4 yr) adults, cutaneous vascular conductance (CVC) was measured at four forearm skin sites infused with 1) Ringer (Control), 2) 50 mM tetraethylammonium (TEA), a nonspecific KCa channel blocker, 3) 10 mM ketorolac, a nonspecific COX inhibitor, or 4) 50 mM TEA ϩ 10 mM ketorolac via intradermal microdialysis. All skin sites were coinfused with incremental doses of SNP (0.005, 0.05, 0.5, 5, and 50 mM each for 25 min). During SNP administration, CVC was similar at the ketorolac site (0.005-50 mM, all P Ͼ 0.05) relative to Control, but lower at the TEA and TEA ϩ ketorolac sites (0.005-0.05 mM, all P Ͻ 0.05) in young adults. In older adults, ketorolac increased CVC relative to Control during 0.005-0.05 mM SNP administration (all P Ͻ 0.05), but this increase was not observed when TEA was coadministered (all P Ͼ 0.05). Furthermore, TEA alone did not modulate CVC during any concentration of SNP administration in older adults (all P Ͼ 0.05). We show that during low-dose NO administration (e.g., 0.005-0.05 mM), KCa channels contribute to cutaneous blood flow regulation in young adults; however, in older adults, COX inhibition increases cutaneous blood flow through a KCa channel-dependent mechanism.
of NO donor such as sodium nitroprusside (SNP), for instance, is widely used to assess endothelium-independent vasodilation (i.e., vascular smooth muscle cell function). However, exogenous NO-induced vasodilation may not necessarily reflect endothelium-independent vasodilation since NO can influence other pathways. In line with this, local heating-induced transient cutaneous vasodilation, which is mainly mediated by sensory nerves (40) , is attenuated by inhibition of NOS (21) , suggesting that NO may sensitize sensory nerves. Furthermore, NO may induce cutaneous vasodilation by influencing endothelium-derived relaxing factors that include cyclooxygenase (COX) and endothelium-dependent hyperpolarization, the latter of which is mediated through calcium-activated potassium (KCa) channels (12) . Indeed, both KCa channels and COX contribute to cutaneous blood flow regulation in humans in vivo (5, 7, 8, 33, 36) and NO can activate KCa channels (3, 42) and COX (48) as suggested in cultured cell studies. However, whether KCa channels and COX contribute to cutaneous blood flow regulation during exogenous NO administration remains unclear in humans.
Aging is associated with diminished NOS-dependent cutaneous vasodilation during local or whole body heating (11, 41, 55) , which can be due to age-related reduction in NO production or bioavailability (19, 54) . As such age-related modulation of NO production or its availability has been well established; however, how aging may modulate the mechanisms involved in the regulation of cutaneous blood flow in response to NO has yet to be determined. Aging is associated with downregulation of KCa channels (1, 34) as well as reductions in the production of COX-derived vasodilator prostanoids (18) . Therefore, aging may reduce the contributions of KCa channels and COX, if any, to the increase in cutaneous blood flow induced by exogenous NO administration.
In the present study, we assessed the relative contribution of KCa channels and COX to the regulation of cutaneous blood flow during administration of NO and how aging may modulate the responses. We evaluated the hypothesis that cutaneous perfusion during exogenous NO administration in young adults is partially regulated through KCa channels and COX, and that the contribution of these pathways is impaired with aging.
MATERIALS AND METHODS
Ethical approval. This study was approved by the University of Ottawa Health Sciences and Science Research Ethics Board in compliance with the Declaration of Helsinki. Verbal and written informed consent was obtained from all volunteers before their participation in this study.
Participants. Ten young (3 males and 7 females) and ten older (3 males and 7 females) physically active (1-6 days per week, Ն30 min of exercise per day) adults participated in the study. The participants did not have a history of cystic fibrosis transmembrane conductance regulator mutations, skin disorders, hypertension, heart disease, diabetes, or autonomic disorders and were not taking prescription medications. To minimize the influence of fluctuations in female sex hormones associated with the menstrual cycle on the cutaneous blood flow response (6, 29) , the young females (none of whom were taking oral contraceptives) participated during the early follicular phase (within 6 days from the beginning of menstruation). All older females were postmenopausal. All participants were screened on a separate day at a preliminary session before the experimental session. During the preliminary session, body height was measured using a stadiometer (model 2391, Detecto Scale, Webb City, MO), and body mass was measured by a digital weight scale platform (model CBU150X, Mettler Toledo, Schwerzenbach, Switzerland). Resting systolic and diastolic pressures were manually obtained from all participants in a seated position by a trained investigator. Participant physical characteristics are presented in Table 1 .
Experimental session. Participants were instructed to avoid overthe-counter medications (including nonsteroidal anti-inflammatory drugs, vitamins, and minerals) for Ͼ48 h before arriving to the laboratory. They were asked to refrain from alcohol, caffeine, and heavy physical activity Ͼ12 h before the experimental session. Furthermore, they were restricted from consuming any food Ͼ2 h before and throughout the session. Upon arrival to the laboratory on the day of the experimental session, the participants provided a urine sample, which was analyzed by a handheld total solids refractometer (model TS400, Reichter, Depew, NY) to determine urine specific gravity (an index of hydration status). Urine specific gravity evaluated before the experiment was 1.015 Ϯ 0.004 and 1.015 Ϯ 0.005 in the young and older adults, respectively, indicating the participants were in a state of euhydration (49) . Thereafter, the participants rested in a recumbent position in an experimental room (ϳ27°C). During this time, four microdialysis fibers (30 kDa cutoff, 10 mm membrane) (MD2000, Bioanalytical Systems, West Lafayette, IN) were inserted in the forearm skin with each fiber separated by Ͼ4 cm. For the fiber placement, a 25-gauge needle was first inserted into the unanesthetized skin using aseptic technique, with the entry and exit points separated by ϳ2.5 cm. The microdialysis fiber was then passed through the lumen of the needle, after which the needle was withdrawn leaving the fiber within the dermal layer of the forearm skin. Each fiber was connected to the outlet port of a liquid switcher (model 110, CMA Microdialysis AB, Kista, Sweden).
Approximately 10 min after fiber placement, each fiber was perfused in a counter-balanced manner with either 1) lactated Ringer (Control, Baxter, Deerfield, IL); 2) 50 mM tetraethylammonium (TEA, Sigma-Aldrich, St. Louis, MO), a nonspecific KCa channel blocker; 3) 10 mM ketorolac (Sigma-Aldrich), a nonspecific COX inhibitor; or 4) a combination of 50 mM TEA and 10 mM ketorolac (Combination). Each drug was administered at a rate of 4.0 l/min with an aid of a microinfusion pump (model 4004, CMA Microdialysis, Solna, Sweden). All solutions were dissolved in lactated Ringer. The concentrations of TEA (5, 7, 28, 33) and ketorolac (20, 26, 36) were determined based on previous studies in which intradermal microdialysis was used in human skin. A previous study confirmed that intradermal administration of 50 mM TEA via mirodialysis specifically targets KCa channels with minimal influence on other potassium channels (5). We did not use specific large-conductance KCa channel blockers such as charybdotoxin and iberiotoxin because they are toxic to humans (45) . Each drug was continuously perfused throughout the experimental protocol until the maximal cutaneous vasodilation procedure began (see below). All drugs were infused for 75 min before the start of data collection to ensure the establishment of each blockade. After the insertion of the microdialysis probes, a minimum rest period of 90 min was employed to ensure trauma associated with the insertion of the probe had subsided (14) .
After the 90-min resolution period, 10 min of baseline data (Baseline) collection ensued. Thereafter, SNP (Sigma-Aldrich), a NO donor, was administrated at a rate of 4.0 l/min in an ascending manner with five different concentrations (0.005, 0.05, 0.5, 5, and 50 mM), each for 25 min. In contrast to previous studies that typically employed an infusion period of 5 to 20 min (4, 27, 30), we chose to use a longer 25-min infusion period at each dose of SNP to ensure a stable cutaneous blood flow response. Each concentration of SNP was dissolved in either lactated Ringer, 50 mM TEA, 10 mM ketorolac, or a combination of 50 mM TEA plus 10 mM ketorolac. This range of SNP concentration was employed to obtain low-to-high cutaneous vasodilation in response to SNP. A previous study demonstrated that 0.05 mM of SNP increased cutaneous vascular conductance (CVC) up to ϳ50%max (25) . Based on this previous result, we determined the necessary concentrations of SNP to obtain CVC values below and above 50%max. We employed 50 mM of SNP as the highest concentration of SNP, a dose that is thought to induce maximal cutaneous vasodilation, to verify if this concentration of SNP can induce a substantial increase in cutaneous blood flow irrespective of the administration of the inhibitor and/or blocker. After the last infusion of SNP (50 mM) was completed, 50 mM of SNP dissolved in Ringer solution (without TEA or ketorolac) was administered at each microdialysis site at a rate of 6.0 l/min to ensure maximal cutaneous vasodilation. This SNP administration lasted for 20 -30 min until a stable plateau for a minimum of 3 min was obtained.
Measurements. Cutaneous red blood cell flux, expressed in perfusion units, was obtained at a sampling rate of 32 Hz with laserDoppler flowmetry (PeriFlux System 5000, Perimed, Stockholm, Sweden). Integrated laser-Doppler flowmetry probes (model 413, Perimed) were centered directly over each microdialysis fiber. Arterial systolic and diastolic blood pressures were manually obtained every 10 -15 min by a trained investigator using a mercury column sphygmomanometer (Baumanometer Standby model, WA Baum, Copiague, NY). Mean arterial pressure was calculated as diastolic pressure plus one-third the difference between systolic and diastolic blood pressures (i.e., pulse pressure). CVC was evaluated as cutaneous red blood cell flux (in perfusion units) divided by mean arterial pressure. CVC data are presented as a percentage of maximal response (%max, determined during the 50 mM SNP administration without TEA or ketorolac infusion at the end of the protocol) to minimize the effect of site-to-site heterogeneity on the measured cutaneous blood flow response (39) .
Data analysis. All values used for data analysis were obtained by averaging measurements made over the last 5 min of each stage (i.e., Baseline, 0.005, 0.05, 0.5, 5, and 50 mM of SNP). The SNP concentration required to elicit half of the maximal cutaneous vasodilation response (EC50, in logM) and slope of the dose-response curve (Hill slope, steeper curve has a higher slope value) were evaluated using a nonlinear regression with four parameters (bottom, top, EC50, and Hill slope) as was reported previously (58) with an aid of commercially available software (GraphPad Prism 6.0; GraphPad Software, La Jolla, CA). To meet the requirement for logistic curve modeling, CVC was normalized within each site by defining the smallest value as 0% and largest value as 100%. We excluded one older adult for EC50, and Hill slope calculation as this participant had an extremely high Hill slope due to a skewed dose-response curve.
Statistical analysis. Based on CVC results obtained in our previous work (10) with 80% power and a significance level of 0.05, a minimum sample size was calculated, indicating required minimal sample size was n ϭ 9. During Baseline and SNP administration, CVC presented as %max was evaluated using a three-way, mixedmodel analysis of variance (ANOVA) with the factors of forearm treatment type (four levels: Control, KCa channel blocker, COX inhibitor, Combination), age (two levels: young adult, older adult), and stage (six levels: Baseline, 0.005, 0.05, 0.5, 5, or 50 mM of SNP). A two-way, mixed-model ANOVA with the factors of forearm treatment type (four levels: Control, KCa channel blocker, COX inhibitor, Combination) and age (two levels: Young adult, Older adult) was employed for EC50 and Hill slope for SNP-induced cutaneous vasodilation as well as maximal absolute CVC (perfusion units mmHg Ϫ1 ). When a significant interaction or main effect was detected, post hoc multiple comparisons were carried out using Dunnett's test for between-treatment comparisons (i.e., vs. Control) and Student's unpaired two-tailed t-tests were used for between-group. The level of significance for all analyses was set at P Յ 0.05. All values are means Ϯ 95% confidence interval. All statistical tests were performed using the software package SPSS 23 for Windows (IBM, Armonk, NY). Figure 1 illustrates time-course changes in CVC in response to SNP. During Baseline, KCa channel blocker reduced CVC relative to the Control site in both groups regardless of whether or not the COX inhibitor was coadministered (all P Ͻ 0.05), whereas independent administration of the COX inhibitor did not affect CVC in young adults (P ϭ 0.70) ( Table 2 ). Administration of the COX inhibitor alone increased CVC during Baseline relative to the Control site in older adults (P ϭ 0.01); however, this response was not observed when the COX inhibitor was simultaneously administered with KCa channel blocker (i.e., a combined administration of KCa channel blocker and COX inhibitor reduced CVC during Baseline compared with the Control site) (P Ͻ 0.01 Table 2 ).
RESULTS
During SNP administration, the COX inhibitor did not modulate CVC compared with the Control site at any dose of SNP in young adults (all P Ͼ 0.27) (Fig. 2A) . In contrast, the KCa channel blocker attenuated CVC relative to the Control site when delivered independently (both P Յ 0.01) as well as in combination with the COX inhibitor (both P ϭ 0.05) at the 0.005 and 0.05 mM dose of SNP administration (Fig. 2A) . In older adults, the COX inhibitor induced higher levels of CVC relative to the Control site (both P Յ 0.01), but this was not observed when the KCa channel blocker was coinfused (both P Ն 0.99) at the 0.005 and 0.05 mM dose of SNP administration (Fig. 2B) . KCa channel blocker did not affect CVC during any dose of SNP administration (all P Ͼ 0.38) in older adults. (Table 3) .
DISCUSSION
A key finding of our study was that during lower concentrations of NO administration (0.005-0.05 mM), the KCa channel blocker, but not the COX inhibitor, reduced CVC in young adults. In contrast, we showed that the COX inhibitor increased CVC during 0.005-0.05 mM SNP administration in older adults, which was not observed when the KCa channel blocker was coadministered.
Cutaneous vasodilation. Exogenous NO administration is believed to induce endothelium-independent vasodilation, as NO directly affects soluble guanylyl cyclase in the vascular smooth muscle cells to induce vasodilation (25) . However, in the present study, we show that KCa channels also contribute to cutaneous blood flow regulation during low-dose NO ad- ministration in young adults ( Fig. 2A) , which may be associated with NO-induced activation of KCa channels as reported in vitro (3, 42) . Since activation of KCa channels located on endothelial cells induces endothelium-dependent hyperpolarization and thus vasodilation (12), our results suggest that endothelium-derived relaxing factor may contribute to the regulation of cutaneous blood flow with low doses of SNP administration. On the other hand, we showed that COX does not contribute to cutaneous blood flow control during SNP administration in young adults ( Fig. 2A) . Our result for COX is consistent with the findings of previous studies (31, 44) wherein they employed iontophoresis, a method of applying a local electric current to the skin, which can itself induce a current-dependent vasodilation (9) . The contribution of KCa channels to the increase in cutaneous blood flow during low-dose SNP administration, which was observed in young adults, was not evident in older adults (Fig. 2B) . Thus aging (ϳ54 yr) appears to diminish the contribution of KCa channels to cutaneous blood flow regulation when NO bioavailability modestly increases. This finding may be a result of an age-related reduction in number of KCa channels (1, 34) . Although KCa channels similarly contribute to basal cutaneous blood flow in both young and older adults (Table 2) , due to less KCa channels in the aged skin, the influence of KCa channels may be overpowered by other vasodilator effect(s) induced by SNP administration. Alternatively, another mechanism may explain our results. NO binds with superoxide which forms peroxynitrite. When NO bioavailability increases during low dose SNP administration, peroxynitrite formation may be augmented in older adults as aged skin typically exhibits greater levels of superoxide relative to young skin (57) . This increased peroxynitrite formation may reduce the contribution of KCa channels to the regulation of cutaneous blood flow during low dose SNP administration, as peroxynitrite can inhibit KCa channel activity (32) . Further studies using an antioxidant such as ascorbate would elucidate this possibility.
In contrast to young adults, we showed that in older adults, COX inhibition resulted in increases in CVC during low-dose SNP administration (Fig. 2B) , suggesting that aging may modulate COX-dependent mechanism(s) underpinning regulation of cutaneous blood flow. Thus in older adults, endothelial cells appear to modulate cutaneous blood flow regulation during low-dose SNP administration through COX. In other words, cutaneous vasodilation during low-dose SNP administration in older adults may not always reflect endothelium-independent vasodilation. However, the modulation of COX was not observed when both the COX inhibitor and KCa channel blocker were administered simultaneously (Fig. 2B) , suggesting that the increased cutaneous blood flow induced by COX inhibition is a result of a KCa channel-dependent mechanism(s). COX can increase superoxide (22) , which may result in an attenuated KCa channel activity secondary to increased peroxynitrite formation, as discussed above. Alternatively, aging may lead to increases in COX-derived thromboxane A2 (46) , which can also inhibit KCa channel activity (50) . This may underlie the fact that COX inhibition increases cutaneous blood flow during low-dose SNP administration in older adults through KCa channel-dependent mechanisms. Furthermore, COX inhibition can yield more arachidonic acid for cytochrome P-450 epoxygenase 2C9, resulting in increase in production of epoxyeicosatrienoic acids (EETs). EETs have been shown to increase cutaneous blood flow by activating KCa channels during local heating in humans in vivo (7) . Hence the KCa channel blocker in the presence of the COX inhibitor may inhibit action of Data are represented as means Ϯ95 % confidence intervals for the 10 young and 10 older participants (in perfusion units mmHg Ϫ1 ). KCa, calcium-activated potassium, COX, cyclooxygenase. Combination, KCa channel blocker plus COX inhibitor. P Ͼ 0.14 for main effects of group and forearm treatment type, and an interaction between group and forearm treatment type.
EETs, thereby blunting the increase in cutaneous blood flow induced by COX inhibition to levels comparable to that measured at the Control site.
Although our results showed that KCa channels and COX contribute to the regulation of cutaneous blood flow during low-dose SNP administration in both young and older adults (Fig. 2) , similar mechanisms exist during Baseline ( Table 2 ). The roles of COX and KCa channels in young (5, 7) and older (18, 20) adults in baseline cutaneous blood flow have been previously documented. When the difference in CVC during Baseline was considered (i.e., evaluated as EC50 and Hill slope), the influences of KCa channels and COX on the cutaneous blood flow during low-dose SNP administration were no longer observed. Furthermore, CVC did not differ between the four sites during higher doses of SNP administration (Fig. 2) . Therefore, a significant portion of the increase in CVC in response to low-dose SNP administration appears to be mediated through KCa channel-and COX-independent mechanisms. This could be associated with NO-induced activation of soluble guanylyl cyclase (25) . In addition, there is evidence to suggest that stimulation of sensory nerves (43) and ATPsensitive potassium channels (16) may contribute to the cutaneous vasodilatory response elicited by SNP administered via iontophoresis; however, it is currently unknown if these mechanisms would contribute during SNP perfusion via microdialysis wherein there is no current-mediated vasodilation.
No differences in CVC were observed between young and older adults at the Control site during any dose of SNP administration (Fig. 2) , which is consistent with previous work (47) . However, an attenuated cutaneous blood flow response to SNP administration in older adults has also been reported (2, 56) . Furthermore, we observed similar absolute maximal CVC between groups (Table 3) , which contradicts a previous study by Martin et al. (35) who showed an age-related reduction in maximal cutaneous blood flow. While the underlying reasons for the discrepant findings between studies are unclear, it is important to note that Martin et al. (35) employed venous occlusion plethysmography, which provides an estimate of cutaneous blood flow of the limb, whereas we employed laser-Doppler flowmetry, which limits the measurement of cutaneous blood flow in a relatively small area of the skin (integrated lase-Doppler probe employed in the current study covers area of ϳ0.3 cm 2 ). This methodological difference may underlie the discrepancy between our study and the study by Martin et al. (35) . However, it is important to note that our results clearly show age-related alternations in COX-dependent and KCa channel-dependent mechanisms despite the lack of an age-related differences in the cutaneous blood flow response to NO and maximal absolute CVC. It is possible that other factors as discussed above (i.e., soluble guanylyl cyclase, sensory nerves, and/or ATP-sensitive potassium channels) may play an important role in modulating the increase in cutaneous blood flow during low doses of SNP administration in older adults relative to their younger counterparts.
Considerations. In the present study we employed the lowest concentrations of ketorolac and TEA that have previously been shown to induce maximal changes in cutaneous blood flow (20, 33) . While we did not directly verify the efficacy of the drugs in the present study, we measured significant effects of ketorolac and TEA on CVC at Baseline and during the administration of low concentrations of SNP. As such, we believe that we successfully achieved an inhibition of COX and KCa channel blockade, though we cannot directly determine whether we completely abolished the actions of COX and KCa channels.
Mean age of the participants in the older group of present study was 54 yr. It is possible therefore that we may have seen a more pronounced effect of age had we studied participants who were older than this. However, age-related alterations in the mechanisms underpinning control of cutaneous blood flow have been reported to occur even in middle-aged adults (4, 18). Thus we believe that our observations would not differ markedly from what we measured in the current study even if we had employed participants Ͼ54 yr of age. Furthermore, for both young and older groups, a greater number of females relative to males (7 of 10) were studied. While our results could be considered to be more representative of the response in females, we observed comparable patterns of responses in both males and females.
Although we observed a significant modulation of CVC during low-dose (i.e., 0.005-0.05 mM) SNP administration with KCa channel blocker in young adults and COX inhibitor in older adults, these differences are no longer observed when differences in baseline CVC (i.e., EC50 and Hill slope) are considered.
Perspectives and Significance
SNP is widely used to assess endothelium-independent vasodilation. However, we show that KCa channels and COX (both can induce endothelium-dependent vasodilation) contribute to CVC during lower dose SNP administration. Thus cutaneous vasodilation occurring during low-dose SNP administration (0.005-0.05 mM) may not solely reflect endotheliumindependent vasodilation. However, CVC during higher dose SNP administration (0.5-50 mM) was not influenced by coadministration of COX inhibitor and/or KCa channel blocker in the present study. Therefore, when evaluating endotheliumindependent cutaneous vasodilation using intradermal microdialysis in young and older adults, we recommend using SNP concentrations of Ն0.5 mM.
Our results obtained with exogenous NO administration may provide insight into how endogenous increases in NO may modulate cutaneous blood flow. A recent study by Brunt et al. (5) demonstrated that whole body heating increased CVC, and the level of increase at Ͻ0.6°C increase in core temperature was comparable to that observed during the administration of 0.05 mM of SNP in the young adults of the present study (i.e., ϳ40%max of CVC). Their results also indicated that both NOS and KCa channels contribute in an interactive manner to the regulation of CVC during whole body heating (5), though the mechanism(s) underlying this response remains unclear. Based on the results obtained from the current study, it is plausible that endogenous increases in NO may activate KCa channels, contributing to the increase in CVC observed during whole body heating (5) . Furthermore, a study by Holowatz et al. (18) showed that in middle-aged adults (53 years), COX inhibition augmented cutaneous vasodilation during a mild passivelyinduced heat stress (i.e., whole body heating resulting in an increase in core temperature of Ͻ0.4°C), which they demonstrated was a result of NOS-dependent mechanisms. Based on our results, we can surmise that the endogenous increase in NO may activate COX thereby attenuating cutaneous vasodilation during whole body heating in middle-aged adults.
In conclusion, we demonstrate that KCa channels, but not COX, contribute to cutaneous blood flow control during NO administration in young adults. We also show that COX inhibition increases cutaneous blood flow during NO administration in older adults through KCa channel-dependent mechanisms.
